# CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
> **ANDA203466** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS LIFESCIENCES · Approved 2017-11-27
## Drug
- **FDA Application Number:** ANDA203466
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
- **Generic name:** CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS LIFESCIENCES
- **Manufacturer:** Zydus Lifesciences Limited
- **First approval:** 2017-11-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203466)
---
*AI Analytics · CC0 1.0*